Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes. The majority of "reinstatements" were for foreign securities (the ones with F as the fifth letter in their ticker). Even today's daily list shows a bunch of reinstatements for these foreign securities. However, there were a few stocks that were not foreign that were reinstated.
BKCT is one such example. It was suspended 7/30/19 because of a lack of filings since 2016. It resumed trading on the greys on 8/12/19. It was then revoked by the SEC/Finra 8/20/19 before market open. But then a few minutes later before the market opened... bam.... "Reinstated, deleted in error". Not sure why it was reinstated but it was. Hasn't traded more than a few shares since, but it's still available. It's just a matter of time before it gets the boot permanently imo.
Anyway, see the daily list for yourself. I can't link to the daily list for that day directly, but if you do a search on the daily list and enter the symbol and a wide range in date encompassing the date listed above, you will see what I mean. https://otce.finra.org/otce/dailyList
No. I know a bunch of other tickers trading on the greys. Majority were suspended by the SEC at some point, but a few that weren't. I'm sure they'll get the axe eventually if they don't do something to bring themselves back to the pinks
Will certainly be interesting to see what happens. I have seen some deletions on the daily list one day and then a few days or weeks later come back on the daily list as an addition with the explanation that they were "deleted in error" or in some cases "reinstated" by Finra.
$20 was a good lotto amount. BSYN definitely was the most attractive since it was up-to-date in filings and had a ridiculously low AS/OS.
Since it hadn't been traded in almost 2 years, the deletion due to inactivity doesn't look like a Finra mistake
not familiar with NONT.
you had open orders for BSYN? i never pulled the trigger to place an order. you really dodged a bullet then!
no more monitoring for me. i'm gonna only play the ones that do make it off the greys. not going to buy any before that.
yeah. i'm surprised too.. i was considering buying in that one b/c of the grey to pink moves thinking that might be the next one! dodged a bullet there! phew
seems Finra is cracking down on greys today by deleting a whole bunch
https://otce.finra.org/otce/dailyList
SOAN up a little on news today
https://www.otcmarkets.com/stock/SOAN/news/story?e&id=1607488
AngioSoma's Development of Atherectomy Catheter
Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s peripheral arterial disease (“PAD”) product, Atherectomy Catheter II, is a catheter-based platform capable of treating a broad range of plaque types, including calcified plaque and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. This device uses a camera that allows physicians to better control treatment of PAD patients. We have not applied to the United States Food and Drug Administration for clearance to market the Atherectomy Catheter II as a treatment for severely calcified coronary arteries.
In addition, the Atherectomy Catheter II includes a vacuum mechanism that extracts any removed plaque from the arteries and from the patient.
According to estimates by the American Heart Association, as many as 8 to 12 million Americans have PAD. In addition, a study by The SAGE Group, based on the diabetes method, estimated prevalence at 17.6 million in 2010 (The SAGE Group, “The Diabetes Method,” 2011). An aging population, coupled with increasing incidence of diabetes and obesity, is likely to continue to increase the prevalence of PAD. Guidelines from the American College of Cardiology Foundation/American Heart Association in 2011 lowered the recommended age for testing for PAD from 70 to 65, or 50 if the patient has a history of smoking or diabetes. As these guidelines are incorporated into physician practice, PAD diagnosis rates are forecasted to increase.
AngioSoma President, Alex Blankenship, said, “We are extremely pleased to own this very promising technology and look forward to going forward with the United States Food and Drug Administration to authorize our innovative catheter into the market.”
About AngioSoma, Inc.
AngioSoma is a wellness company dedicated to bringing innovative, effective and high-quality supplement products and medical devices to the medical, wellness and adult-use markets through our marketing subsidiary, SomaCeuticals™.
Learn more at www.muscles4U.com and htttps://muscles4u.blogstop.com. Stay up to date at Twitter: @tweetmuscles4u, Instagram and Facebook.
Notice Regarding Forward Looking Statements
This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
CONTACT
AngioSoma, Inc.
Alex Blankenship
Alex@AngioSoma.com
(832) 781- 8521
Source: AngioSoma, Inc.
© 2020 GlobeNewswire, Inc.
attorney letter out today. should become pink current on otcmarkets soon
https://www.otcmarkets.com/stock/ARSN/disclosure
enter either name - Las Vegas Xpress, Inc
or Entity number - E0094552016-9
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
enter either name - Las Vegas Xpress, Inc
or Entity number - E0094552016-9
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
reinstated on NV SOS today
Besides quarterly filings, a yearly attorney letter is necessary to attain Pink Current status on otcmarkets.com.
attorney letter just posted
https://backend.otcmarkets.com/otcapi/company/financial-report/245625/content
6/19, 9/19, 12/19, 3/20 quarterly filings just out
6/19
http://archive.fast-edgar.com//20200429/AO22722CLC22M922222L2ZY25V2V22224222/
9/19
http://archive.fast-edgar.com//20200429/AO22722CLC22M2B2222L2WY25V29C2224222/
12/19
http://archive.fast-edgar.com//20200429/AO2Z722CLC22M2B2222L2WY25V2PZ2224G22/
3/20
http://archive.fast-edgar.com//20200429/AO22722CLC22M922222L2ZY25V23M2224222/
12/18-12/19 annuals out!
https://www.otcmarkets.com/stock/rnwf/disclosure
hopefully something happens soon
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
Search either by name for "Cannabiz Mobile, Inc."
or search by Entity number for "C18237-1995"
reinstated just now
reinstated today
Sorry. Not sure how I saw David Lazar originally, but the reinstatement was actually by Rhonda Keaveney. Just noticed my error when I saw the Motion to Terminate Custodianship today and noticed it was Small Cap Compliance which is Rhonda's company.
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=8XKEodxKP1RsBqrGsTXxeA2&tabIndex=3
Not sure
Custodian discharged today. Seems more likely that possible deal is done!
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=99BI3T9H9st57oxansu2JQ2&tabIndex=3
Don't know if it's been sold or what. I just noticed the director change from Rhonda Keaveney to Robert Chin. Seems to me that something is in the works. Hopefully we hear a good update soon.
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
Put in Evermedia Group, Inc. and search.
Robert Chin now in charge. Seems like whatever deal Rhonda was looking for went through and thus there is a new President
reinstated by David Lazar last night on NV SOS
Not sure. Best to ask the David Lazar $hell Play board. Guys there would know.
Besides the name change, the same filing shows the AS has been lowered from 7b to 500m.
wtf! am i missing something?
articles of merger on NV SOS out just now!
HYPERTENSION DIAGNOSTICS Inc., (HDII) Meeting with Shanghai CinTel Intelligent Ltd.
TORONTO, ON / ACCESSWIRE / February 20, 2020 / Mr. Peng Liangjian, CEO of Hypertension Diagnostics Inc. (OTC PINK:HDII), had a meeting with Mr. Zheng Ding, the chairman of Shanghai CinTel Intelligent Ltd. (CinTel) on February 14, 2020. Mr. Peng introduced Hypertension Diagnostics Inc (HDII) and US Stock Markets to Cintel. Mr. Ding is interested in North American capital markets, and the two discussed the possibilities of bringing the China based company to the U.S. stock markets.
About Shanghai CinTel Intelligent Ltd.
Shanghai CinTel Intelligent Ltd. was established in July 1998, focusing on the deep integration of big data, AI and IoT application technologies. It is a provider of intelligent communication services, big data applications and IoT application solutions. Based on the combination of independent research and development core technology and open source technology, CinTel has created a smart convergence business support platform and a one-stop big data analysis platform.
About Hypertension Diagnostics Inc.
Hypertension Diagnostics, Inc. is a public company currently trading on the OTC Markets (OTC: HDII). HDII was originally corporate in Minnesota .
*Safe Harbor Statement Information in this press release may contain 'forward-looking statements.' Statements describing objectives or goals or the Company's future plans are also forward-looking statements and are subject to risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those anticipated. Forward-looking statements in this news release are made pursuant to the 'Safe Harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to sales, acceptance of Hypertension Diagnostics Inc.'s products, increased levels of competition, changes, dependence on intellectual property rights and other risks detailed from time to time in Hypertension Diagnostic Inc. periodic reports filed with the regulatory authorities.
CONTACT:
Jeff Peng
jeff.torcn.com@gmail.com
SOURCE: Hypertension Diagnostics Inc.
View source version on accesswire.com:
https://www.accesswire.com/577143/HYPERTENSION-DIAGNOSTICS-Inc-HDII-Meeting-with-Shanghai-CinTel-Intelligent-Ltd
He pasted the wrong filing. This is the custodianship filing for Exobox
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=ejYuZmCsj4As2NHnRlq6Nw2&tabIndex=3
A-20-810738-B | Custodian Ventures, LLC, Plaintiff(s) vs. Exobox Technologies Corp. [Nevada Entity No. C30664-1999], Defendant(s)
Case Number
A-20-810738-B
Court
Department 11
Judicial Officer
Gonzalez, Elizabeth
File Date
02/19/2020
Case Type
NRS Chapters 78-89
Case Status
Open
Party
Plaintiff
Custodian Ventures, LLC
Active Attorneys
Lead Attorney
Chasey, Peter L.
Retained
Defendant
Exobox Technologies Corp. [Nevada Entity No. C30664-1999]
Events and Hearings
02/19/2020 Initial Appearance Fee Disclosure
Comment
Initial Appearance Fee Disclosure
02/19/2020 Motion
Comment
Motion for Appointment of Custodian
custodianship application today
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=QOYddPsA13H1Ep-2HjfYKw2&tabIndex=3
filings just posted https://www.otcmarkets.com/stock/crge/disclosure
Now we wait for the custodian to find a buyer to reverse merge into this shell.
Yes, the custodianship for GESI was granted yesterday. It's a good thing!